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Abstract
Background—Up to 30% of young adults with velocardiofacial syndrome (VCFS; 22q11.2
deletion syndrome) develop schizophrenia or psychosis. Identifying the neuroanatomic trajectories
that increase risk for psychosis in youth with this genetic disorder is of great interest.
Methods—We acquired high-resolution anatomic MR images and measures of psychiatric
function on 72 youth with VCFS, 26 unaffected siblings and 24 age-matched community controls
at two timepoints, between late childhood (mean age, 11.9 years) and mid-adolescence (mean age,
15.1 years).
Results—With the exception of cranial gray matter and orbitofrontal prefrontal cortex,
neuroanatomic trajectories in youth with VCFS were comparable to unaffected siblings and
community controls during this developmental window. However, in youth with VCFS,
longitudinal decreases in the volumes of cranial gray and white matter, prefrontal cortex, mesial
temporal lobe, and cerebellum were associated with increased combined prodromal symptoms at
Time 2. In contrast, only decreases in temporal lobe gray matter volumes (p < .002) and verbal IQ
(p < .002) predicted specifically to positive prodromal symptoms of psychosis at Time 2.
Conclusions—These findings are in line with studies of non-VCFS individuals at risk for
schizophrenia, and suggest that early decrements in temporal lobe gray matter may be predictive
of increased risk of prodromal psychotic symptoms in youth with VCFS.
Keywords
22q11.2 deletion syndrome; brain development; MRI; longitudinal; temporal lobe; prodromal;
psychosis; schizophrenia
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INTRODUCTION
Velo-cardio-facial syndrome (VCFS), also known as 22q11.2 deletion syndrome and
DiGeorge syndrome, is caused by an interstitial deletion of approximately 40 genes at the
q11.2 locus of chromosome 22 (1). Children with VCFS have physical anomalies,
intellectual deficits and psychiatric disorders. Common childhood disorders include
attention deficit hyperactivity disorder, phobias, generalized anxiety disorder and major
depression (3,4). As youth with VCFS reach adulthood, up to 32% develop psychotic
disorders, including schizophrenia and schizo-affective disorder (2,5–8). Accordingly,
VCFS is the highest known genetic risk factor for schizophrenia next to having two parents
with the illness (9). The onset of psychosis in young adults with VCFS is accompanied by a
decline in verbal IQ (2).
The high co-occurrence of schizophrenia and VCFS has increased interest in identifying
biological risk factors for psychosis in VCFS individuals. Since neuroanatomic anomalies in
the non-VCFS population have been reported [albeit inconsistently, see review by Pantelis
(10)] in youth at familial (11–14) and clinical (15) high risk for schizophrenia, and in first
episode patients with schizophrenia (16,17), several studies have focused on the brain
structure of individuals with VCFS. Like youth at risk for schizophrenia, youth with VCFS
display reductions in volumes of the hippocampus (18), inferior frontal lobe (19) and
anterior cingulate gyrus (20). In addition, associations have been reported between volumes
of temporo-occipital cortex and corpus striatum, and schizotypy in VCFS (21). However
without longitudinal data, it is not clear whether these neuroanatomic anomalies are early
markers for psychosis or characteristics of VCFS.
Only one longitudinal study of volumetric alterations (22) and another of cortical thickness
(23) in youth with VCFS have been published. Gothelf and colleagues (22) examined
neuroanatomic trajectories in nineteen individuals with VCFS and eighteen controls. Youth
with VCFS displayed significant longitudinal reductions in amygdala volumes, and
longitudinal increases in superior temporal gyrus gray matter, cranial white matter and
cerebellar white matter. Although longitudinal decline in verbal IQ was associated with
psychotic disorder at Time 2, longitudinal alterations in neuroanatomic regions of interest
were not. Similarly, Schaer and colleagues (23) did not observe an association between
longitudinal alterations in cortical thickness and psychosis, although they observed cortical
thickness reductions in superior and inferior temporal gyri in a cross-sectional sample of
adults with VCFS and psychosis relative to VCFS-affected adults without psychosis.
Herein, we report a longitudinal study of youth with VCFS, their unaffected siblings and
community controls. Based on the literatures cited above, we measured several
neuroanatomic regions of interest including lobar gray and white matter (22,24), frontal lobe
subregions ((25,26), amygdala (27),hippocampus (12,27), superior temporal gyrus
(24,27,28), and cerebellum (24). By recruiting over 70 youth with VCFS and administering
dimensional and categorical measures of psychosis, we address limitations of previous
longitudinal studies of VCFS, which were underpowered to detect associations between
neuroanatomic trajectories and psychosis.
We hypothesized: 1) relative to controls, volumetric changes between Time 1 and Time 2
would be observed in amygdala, superior temporal gyrus, cranial white matter and
cerebellum; 2) associations would be observed between a decline in verbal IQ score and
prodromal symptoms; and 3) volumetric changes between Time 1 and Time 2 in
hippocampus, temporal gray matter, and inferior frontal lobe would predict to prodromal
symptoms.
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METHODS
Participants
156 participants were enrolled in the longitudinal study of risk factors for psychosis in
VCFS. Recruitment methods were described previously (29). Families of children with
cytogenetically-confirmed VCFS were recruited from the VCFS International Center at
SUNY Upstate Medical University. Unaffected siblings of VCFS participants were included
as a separate study group to account for potential familial effects on development.
Community controls were recruited through fliers at local schools. Exclusion criteria for all
participants were seizure disorder, fetal exposure to alcohol or drugs, parent-reported
elevated lead levels or birthweight under 2500 grams, loss of consciousness lasting longer
than 15 minutes, paramagnetic implants, or orthodontic braces. Potential controls with a
personal or family history of schizophrenia or bipolar disorder were excluded.
MRI Acquisition and Processing
MRIs were acquired at both time points in the axial plane on a 1.5 T Philips Gyroscan
scanner (Philips Medical Systems, Best, The Netherlands) utilizing the following T1-
weighted inversion recovery, turbo gradient echo (TFE) 3-D pulse sequence: echo time = 4.6
ms; repetition time = 20 ms; 2 repetitions; matrix size 256 × 154; field of view = 24 cm;
multishot = 32; TFE pre-inversion recovery = 394 ms, 1.5 mm slice thickness.
Imaging data were imported into the image processing program, BrainImage. A previously
published (30–33) semi-automated procedure was implemented to measures volumes of
gray and white tissue compartments of lobar regions of the brain. In addition, previously
published, reliable protocols were implemented to generate manually-traced measurements
for subregions of the frontal lobe (34–36), amygdala (29,37), hippocampus (35,37), superior
temporal gyrus (38), cerebellum (unpublished) and ventricles (39). Intraclass correlation
coefficients (ICC), calculated to determine inter-rater reliability for each of these measures,
ranged from .96 to .99 for the segmentation procedure, and .91 to .99 for manually-traced
measures.
Psychological and Psychiatric Assessment Tools
At both timepoints, intellectual function was assessed with the Wechsler scales (40) and
psychiatric status was assessed with the K-SADS-PL. The K-SADS-PL was administered at
each timepoint by one of two investigators (K.A. and W.F.). The mean kappa coefficient
across all diagnoses was .91.
The Scale of Prodromal Symptoms (SOPS)(41) was administered to all participants by a
doctoral – level clinician during the structured psychiatric interview at Time 2. Inter-rater
reliability, based on ratings of five consecutive, audio-taped SOPS interviews by the two
clinicians noted above, and assessed with the ICC, was 0.90. The SOPS comprises four
clinician-rated domains: positive prodromal symptoms, negative prodromal symptoms,
disorganization and general symptoms. Since many of the children in our study had
difficulty responding to a psychiatric interview, we slightly reworded the questions to permit
administration to the child's parent (42). Ratings were based on a Likert-type scale.
Summary scores for the four symptom domains were calculated.
We calculated two scores from the SOPS as outcome measures: 1) total SOPS summary
score (SOPS Total) from Positive, Negative and Disorganization subscales of the SOPS
(thus excluding the relatively non-specific General subscale); and 2) summed scores from
the SOPS Positive symptom scale (SOPS Positive Symptoms), since positive symptoms are
the most specific to psychosis.
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Data Analyses
Multivariate analyses of co-variance (MANCOVAs) compared the neuroanatomic volumes
between study groups at Time 1 and Time 2. Whole brain volume was entered as a covariate
for tissue or CSF measures, including prefrontal subregions, amygdala, hippocampus,
cerebellum and ventricles. Analyses of lobar gray matter (frontal, parietal, temporal,
occipital) and superior temporal gyrus gray matter were adjusted for cranial gray volumes,
and analyses of lobar white matter regions and STG white matter were adjusted for cranial
white matter volumes. All MANCOVAs yielded significant Wilk's Lambda scores, and were
followed up with planned, univariate comparisons.
Repeated-measures multivariate analyses of variance models tested for longitudinal effects,
with diagnostic group as the main effect, and neuroanatomic volumes and time as repeated
factors. Group and time effects and group-by-time interaction were examined.
To test the association between SOPS Total scores, SOPS Positive Symptoms and
neuroanatomic variables, we calculated neuroanatomic change scores for each region of
interest, using the following equation (22): ((T2 volume−T1 volume)×100)/(T1
volume×interval between scans in years). Associations between change scores and the SOPS
were assessed with the Zero-inflated Poisson (ZIP) regression analyses (43) due to the
distribution of our SOPS data, which was a count of symptoms for which at least 50% of
scores equaled zero (indicating the absence of any prodromal symptoms). We performed the
Vuong test to determine if the proportion of scores equaling zero warranted traditional
Poisson regression or ZIP regression. Based on the results of the Vuong test, we conducted
the ZIP analysis for all variables (42).
In an effort to replicate previous longitudinal findings (22), we used Poisson regression to
investigate the association between longitudinal changes in full-scale and verbal IQ scores
and prodromal symptoms at Time 2.
For each set of analyses (MANCOVA, repeated measures, and ZIP regressions),
comparisons were Bonferroni-corrected, resulting in a significance threshold of p ≤ .006. P-
values greater than .006 and less than or equal to .01 were considered trends.
We used Receiver Operating Characteristic (ROC) curve analysis to determine the potential
for making accurate predictions of prodromal symptom status from brain regions
significantly associated with SOPs scores. ROC analysis assesses the accuracy of diagnostic
tests (44) (45–48).
We defined prodromal symptom status as positive if the SOPS Total score was 0.5 standard
deviations above the VCFS mean. We then used logistic regression to predict this binary
prodromal symptoms status variable from the brain regions associated with SOPS Total
scores. For each subject, we computed the predicted values, or logits, from logistic
regression. For each successive point on the logit scale we computed a sensitivity and
specificity of the logit as a predictor of prodromal status by predicting those higher than the
cut-point to be prodromal and others not to be prodromal. The sensitivities and specificities
at each cut-point were used to draw the ROC curve. On the ROC graph, the sensitivity of
different logit cut-points are graphed on the Y axis along with 1 minus the specificity on the
X axis. The higher the graph extends toward the upper left corner of the graph, the higher
the discriminatory power of the logit.
ROC analysis summarizes diagnostic efficiency with the area under the curve (AUC)
statistic, which ranges from 0.5 (for a diagnostically useless predictor) to 1.0 (for a perfect
predictor). The AUC is equivalent to the Mann-Whitney U-statistic computed from a
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comparison of a continuous score between two groups (49) and it equals the probability that
a randomly selected prodromal case will have a more extreme logit score than a randomly
selected non-prodromal subject (49,50).
RESULTS
Sample characteristics
At Time 1, 86 youth with VCFS (Mean age = 11.9 years, SD = 2.1), 33 siblings of youth
with VCFS (sibling control; Mean age = 12.3 years, SD = 2.0) and an age- and gender-
matched group of 37 community controls (Mean age = 12.1 years, SD = 1.8) participated.
No age [F (2, 155) = 0.55, p = .575, η2 = .007] or gender [χ2 (df = 2) = 2.78, p = .25]
differences existed between the groups at Time 1.
A total of 122 youth returned for Time 2 follow-up. Time 2 participants included 72 youth
with VCFS (Mean age = 15.1 years, SD = 2.1), 26 siblings of youth with VCFS (Mean age =
15.2 years, SD = 2.0) and 24 community controls (Mean age = 15.0 years, SD = 1.9). No
age [F (2, 121) = 0.05, p = .95, η2 = .001] or gender differences [χ2 (df = 2) = 0.9, p = .64]
existed between the groups at Time 2. The mean number of days between Time 1 and Time
2 visits was 1161.8 (S.D. = 179.3), and did not differ between study groups (F (2, 121) =
0.352, p = .70, η2 = .006). A comparison (within each study group) between participants lost
to follow-up and Time 2 returnees indicated no differences on (Time 1) sociodemographic
measures including age, gender, and socioeconomic status. Accordingly, participants who
completed Time 2 assessments represented the broader Time 1 sample. Table S1 (see
Supplement) provides complete participant information. Longitudinal cognitive and
psychiatric alterations in this cohort are described elsewhere (37).
Brain Volumes at Time 1
Table 1 reports volumes of neuroanatomic regions of interest at Time 1. Group differences
in brain volumes at Time 1 were consistent with previous reports from our group on a subset
of the current sample (29,34). Whole brain volume was decreased in VCFS participants
relative to siblings (p < .024) (but not controls), however this difference did not survive
Bonferroni correction. Differences in cranial gray matter volumes between the VCFS and
sibling groups approached significance (p < .008) following Bonferroni correction. No
group differences were detected in total cranial white matter. Multiple analyses of
covariance models were significant for regions comprised of total tissue, gray matter and
white matter. Follow-up, univariate analyses of variance indicated that relative to both
siblings and controls, adjusted volumes of amygdala tissue, frontal lobe gray, and white
matter, and lateral ventricles were significantly increased in participants with VCFS.
Cerebellar tissue, occipital gray and occipital white matter (relative to controls only)
volumes were significantly decreased in VCFS. No group differences at Time 1 were found
for prefrontal subregions, hippocampus (although differences reached trend level), and
superior temporal gyrus volumes. P-values ranges for these analyses are reported in Table 1.
Volumetric trajectories from Time 1 to Time 2
As described in Table 2 and Figure 1, we found nominally significant group differences in
the trajectories of orbitolateral prefrontal (OLPFC) and cranial gray matter volumes between
Time 1 and Time 2. The time by group interaction for the OLPFC was driven by a 14%
increase in OLPFC volumes in controls relative to a 4% increase in siblings and no change
in youth with VCFS. The time by group interaction for cranial gray matter was driven by a
2.7% volumetric decrease in siblings, relative to a 0.2% decrease in controls and a 0.6%
decrease in youth with VCFS.
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In all three study groups, we observed volumetric decreases over time in dorsomedial
prefrontal tissue (between group mean: 8.4%), and frontal (2.8%), parietal (4.3%) and
superior temporal gray matter (6.6%), and volumetric increases in cerebellar tissue (3.3%)
and superior temporal white matter (8.8%). Although the effect of time was also significant
for the overall model of parietal white matter, and approached significance for cranial,
temporal and occipital white matter, post-hoc t-tests indicated that these effects were driven
primarily by significant volumetric white matter increases in the group of participants with
VCFS. In youth with VCFS, cranial white matter volumes increased by 2.9%, parietal by
3.3%, temporal by 7.3% and occipital by 12.4%. With the exception of parietal white matter
volumes in siblings (+3.5%), age-related change in these white matter regions did not reach
significance for non-VCFS participants.
Association Between Neuroanatomic Trajectories and Prodromal Symptoms in VCFS
As noted above, associations between neuroanatomic trajectories and both the SOPS (3-
category) Total score and the SOPS Positive Symptom scores were investigated. Since very
few siblings or controls obtained scores above zero on the SOPS, these analyses were
conducted on participants with VCFS only. Over the three-year time period, volumetric
decreases in multiple brain regions (see Table 3) were associated with SOPS Total scores at
Time 2. In contrast, only decreases in temporal lobe gray matter volumes (p < .002)
predicted to positive prodromal symptoms of psychosis at Time 2 (See Figure 2).
Longitudinal decreases in full-scale IQ predicted to SOPS Total scores (p < .0001), but not
to SOPS Positive Symptoms scores at Time 2. In contrast, longitudinal decreases in verbal
IQ scores predicted to SOPS Positive Symptom scores (p < .002), but not to SOPS Total
scores at Time 2.
We used Receiver Operating Characteristic (ROC) curve analysis to determine the potential
for making accurate predictions of SOPS Summary score diagnostic status at Time 2 from
the significant association seen in Table 3. Figure S1 (see Supplement) plots the ROC curve.
The area under the curve (AUC) statistic was 0.864, which means that, with a probability of
86.4%, a randomly selected prodromal case is likely to have a more extreme logit score than
a randomly selected member of the non-prodromal group.
DISCUSSION
In this longitudinal study, we observed that at Time 1, adjusted volumes of frontal gray and
white matter, amygdala and lateral ventricles were increased in participants with VCFS
relative to siblings and controls, whereas adjusted volumes of occipital gray and white
matter, and cerebellum, were decreased. Neuroanatomic trajectories between Times 1 and 2
were comparable among groups for most regions of interest, except cranial gray matter,
which decreased in siblings but not controls or VCFS youth, and orbitofrontal cortex, which
increased in controls, but not siblings or VCFS youth with. However, the overall significant
effect of time for white matter volumes in several lobar regions was driven primarily by the
group of youth with VCFS, in whom white matter volumes in several posterior lobar regions
of the brain increased significantly. Finally, we observed that in youth with VCFS,
longitudinal alterations in multiple brain regions predicted to total prodromal symptoms,
whereas longitudinal decreases in temporal lobe gray matter volumes and in verbal IQ
predicted specifically to positive prodromal symptoms of psychosis at Time 2.
Cross – Sectional Findings
Group differences observed at Time 1 between youth with VCFS, siblings and community
controls are in line with previous cross-sectional studies of neuroanatomy (32,33)
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demonstrating that frontal lobe (as a whole) is relatively enlarged in children with VCFS,
and that posterior regions of the brain are relatively reduced in volume. The mechanism for
this has not been established, although it is consistent with disruption of early neural crest
development that has been previously described in individuals with this disorder (51).
Interestingly, tissue redistribution involving relative enlargement of anterior brain regions
and relative reduction in posterior brain regions have also been observed in individuals with
non-syndromic clefts (52), suggesting that genetic and molecular factors in early
embryological development may be influencing craniofacial and brain morphology in a
parallel manner (52).
Our findings of enlarged amygdala volumes in youth with VCFS are consistent with our
previously published study (29) conducted on a subset of the current sample. Enlarged
amygdala volumes in VCFS have also been reported by Gothelf and colleagues (22),
although group differences in amygdala volumes did not reach significance in their sample,
which was considerably smaller than the current sample. Previously we reported that
enlarged amygdala volumes in VCFS were associated with higher parent ratings of child
anxiety and aggression (29). A recent report of typically - developing girls (53) supports this
association and suggests, if replicated, that the amygdala may play a role in the clinical
manifestation of anxiety that is frequently reported in VCFS.
Longitudinal Trajectories of Brain Structures
The longitudinal trajectories of most brain regions in VCFS were comparable in direction,
although not necessarily magnitude, to unaffected siblings and community controls. The
lobar trajectories for all study groups are consistent with a substantial literature that
demonstrates a dynamic relationship between gray and white matter in which cerebral gray
matter volumes generally peak and then decrease during adolescence while cerebral white
matter volumes increase (54–58). Moreover, within frontal lobe, the dorsolateral PFC
usually matures relatively later than other frontal lobe subregions (55), potentially
explaining longitudinal changes observed across all study groups in dorso- and orbitomedial
PFC, but not in dorsolateral PFC. Consistent with the study by Gothelf et al.(22),
hippocampal volumes increased significantly across all study groups as well. The only
significant time by group effect was for the orbitolateral cortex, which increased
significantly in controls but not in VCFS participants or their siblings. This suggests that the
developmental trajectories we observed in that region may be due to familial/genetic effects
rather than the 22q11.2 deletion per se.
Our study did not replicate the group differences in brain trajectories that Gothelf and
colleagues (22) reported in STG gray matter or amygdala volumes. Although our
observations of accelerated increases in cranial (and lobar) white matter in youth with VCFS
relative to controls were consistent with the findings of Gothelf et al., we did not observe a
significant interaction between time and diagnosis for those brain regions. This is likely due
to the fact that whereas Gothelf and colleagues compared their VCFS cohort to a single
control group, we compared our cohort to both siblings and controls, potentially reducing
power in our time by diagnosis statistical analyses.
Several cross-sectional studies have observed relative reductions in both frontal and
posterior lobar white matter regions (21,33,59) in children with VCFS. The longitudinal
increases in posterior white matter volumes that we found, and the increases in total cranial
white matter that Gothelf et al. also observed in patients with VCFS are intriguing.
However, as Gothelf and colleagues note, these alterations could reflect a pathological
process, in which lobar white matter volumes continue to increase, or a “catch-up” process
in adolescent youth with this syndrome, by which volumes will stabilize to the point at
which they are comparable to siblings and controls.
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Prediction to Symptoms of Psychosis
Although we found that in VCFS, volumetric decrements over time in cranial gray and white
matter, prefrontal cortex, mesial temporal lobe, and cerebellum were predictive of
prodromal symptoms, only decrements in temporal lobe gray matter predicted to prodromal
positive symptoms of psychosis at Time 2. These changes could represent accelerated
synaptic pruning, biochemical cascades that ultimately influence alteration in brain tissue, or
other, unknown, pathophysiological mechanisms. Interestingly, this finding is consistent
with several longitudinal neuroimaging studies of adolescents at clinical and familial high
risk for schizophrenia, in which youth who either display prodromal symptoms (14) or
transition to psychosis demonstrate gray matter loss over time in superior (60) and inferior
temporal lobe (25), as well as superior (60) and inferior (25,61) frontal lobe, and cingulate
(25). Importantly, however, none of our participants had developed frank psychosis or
received a diagnosis of schizophrenia by Time 2 (although several were experiencing
transient hallucinations). Moreover, the age range of our participants is characterized by
continuing dynamic alterations in the structure of the brain, due to ongoing myelination and
synaptic pruning (10). Accordingly, decrements in temporal lobe gray matter during this
transitional window in time may not necessarily reflect a stable marker of psychosis in youth
with VCFS (10).
Our finding that decline in verbal IQ scores were predictive of positive symptoms of
psychosis is consistent with that of Gothelf and colleagues (22), and with several studies
demonstrating a decline in verbal skills in the years preceding the onset of schizophrenia
(62,63). Accordingly, in combination with Time 1 neuropsychological markers that we have
previously identified in this cohort (42), longitudinal decline in verbal IQ can be considered
a risk factor for severe psychiatric disorder in youth with VCFS.
Our ROC analysis suggests that, in addition to being statistically significant, our finding that
multiple brain regions predict prodromal symptoms may have substantial predictive
accuracy. This is seen by the high AUC statistic of 0.8636 and also by inspection of Figure
S1 (see Supplement). By following the ROC curve from the lower left corner to upper right
corner, we can see how changes in the predictor score cutpoint affect the tradeoff between
sensitivity and specificity. For example, the 12th point on the graph indicates that our logit
score predictor can achieve a sensitivity of 70% and a specificity of 90%, which would be
reasonable for a screening tool meant to identify VCFS children at risk for prodromal
psychosis. Further research is needed because the screening accuracy would likely decrease
somewhat with cross-validation and studies of non-VCFS samples would be needed to
assess generalization.
This study must be considered within the context of its limitations. Although our published
protocol to parcellate subregions of the frontal lobe is highly reliable, it does not correspond
precisely to gyral/sulcal boundaries of frontal subregions, potentially undermining the
construct validity of the measures. Nonetheless, the predictive validity of these measures has
been demonstrated in studies of schizophrenia (36). In addition, our sample was not large
enough to control for the possible effects of medication on neuroanatomic change.
Moreover, as noted above, our sample is just reaching the age at which the risk for
schizophrenia increases. Although several participants in our sample were already exhibiting
prodromal symptoms of psychosis at the second timepoint that were related to temporal lobe
volume loss, we are unable to make more definitive statements about the association
between decrements in brain volume and onset of schizophrenia. Even with these
limitations, our observations are consistent with the findings of studies of non-VCFS
adolescents at risk for schizophrenia, and contribute to our identification of specific,
longitudinal neuroanatomic alterations in VCFS youth that may be predictive of increased
risk for psychosis.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
This figure depicts variability in neuroanatomic trajectories across brain regions, by study
group. With the exception of the plot depicting Time × Study Group Interaction for the
orbitolateral prefrontal cortex (OLPFC), the plots are exemplary of the patterns of
neuroanatomic development we observed for several brain regions. The plot for the
dorsolateral prefrontal cortex (DLPFC) exemplifies the brain regions for which we found no
significant effect of time in any study group. The plots for parietal and superior temporal
gyral (STG) white matter exemplify the brain regions for which we observed a significant
effect of time, indicating volumetric increases in all study groups. The plots for parietal and
STG gray matter exemplify brain regions for which we observed a significant effect of time,
indicating decreases in all study groups.
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Figure 2.
This figure represents the significant association between longitudinal change in the
volumes of temporal lobe gray matter and Time 2 SOPS scores on the Positive Symptom
Scale. The distribution of SOPS Positive Symptom scores prevented us from using a
regression plot. Instead, degree of temporal lobe gray matter change in youth with VCFS
was represented with three categories: 1) no change = mean change score + / − 0.5 standard
deviations; 2) volumetric decrease < 0.5 standard deviations below mean change score; 3)
volumetric increase > 0.5 standard deviations above mean change score.
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Table 3
Results of Zero-Inflated Poisson Regression Analyses of the Association Between Longitudinal Change in
Brain Regions of Interest and Scores on the Scale of Prodromal Symptoms (SOPS) At Time 2 in Youth With
VCFS
Neuroanatomic Region SOPS_Total SOPS_Positive Symptoms
z-score p-value < z-score p-value <
Total Tissue
DLPFC −2.69 0.007 −1.44 0.150
DMPFC 0.50 0.614 −1.45 0.148
OLPFC −5.10 0.0001 0.49 0.622
OMPFC −4.19 0.0001 0.64 0.523
Amygdala −2.73 0.006 −0.87 0.382
Hippocampus −5.48 0.0001 −0.86 0.388
Cerebellum −4.82 0.0001 −1.66 0.098
Gray Matter
Cranial Gray −3.66 0.0001 −1.99 0.047
Frontal −2.45 0.014 −0.62 0.537
Parietal −1.54 0.124 −0.70 0.485
Temporal −5.43 0.0001 −3.14 0.002
Occipital −3.31 0.001 0.22 0.827
STG −2.96 0.003 −0.21 0.832
White Matter
Cranial White −5.23 0.0001 −0.17 0.863
Frontal 1.45 0.148 2.21 0.027
Parietal −4.46 0.0001 0.55 0.579
Temporal −4.58 0.0001 −1.56 0.118
Occipital −4.78 0.0001 −0.24 0.810
STG −5.07 0.0001 −0.01 0.993
Cerebral Spinal Fluid
Ventricles −2.86 0.004 0.30 0.765
Abbreviations: WBV: Whole Brain Volume; DLPFC: Dorsolateral Prefrontal Cortex; DMPFC: Dorsomedial Prefrontal Cortex; OLPFC:
Orbitolateral Prefrontal Cortex; OMPFC: Orbitomedial Prefrontal Cortex; STG: Superior Temporal Gyrus
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